Pharmaceutical Industry Related Content

Here, Mark J. Field M.Sc. FRSB, FIScT, MRPharmS, Owner and Founder of Analgesic Innovation, discusses the ever-pressing need for Analgesic Innovation.

We spoke to Professor Mike Barnes, to discuss the future of medical cannabis and cut through the fake news saturating the field.

Here, the Malta Medicines Authority (MMA) shares a vision which integrates regulatory sciences, innovation, and academic initiatives.

Following the latest legislative and market trends, Ilesol Pharmaceuticals has developed a new product with a shiny future in the CBD industry.

A new public health app by DRUID® measures factors to give an overall score of impairment, evolving the classic idea of drug testing.

Cannabis (hemp) contains up to 150 different terpenes. They not only determine the smell, but they also have valuable properties for the body as studies show. Katharina Zedlacher, from BioBloom GmbH, discusses the effect of terpenes in CBD full extracts.

Dr Vincent Maida discusses his discoveries and pioneering research in the area of using Topical Cannabis-Based Medicines (TCBM) for integumentary and wound management.

Peter Jackson, Executive Director of the AMR Centre, describes new initiatives and partnerships that point the way forward for the UK’s antimicrobial resistance response.

Two-Fifths of Brits think it is  “not safe” to drive after taking CBD, according to YouGov study.

Here Kathleen Denoodt explains the role of ECDD and why she believes the recommendations of the investigative report should be followed.

Prof Colin J Suckling OBE DSc FRSE from the Department of Pure & Applied Chemistry, details the ‘why’ and ‘what’ of academic drug discovery research at the University of Strathclyde, as well as his thoughts on the value of a chemistry degree.

With attention turning in the U.S. and elsewhere to how cannabis businesses are banked, John Binns, Partner at BCL Solicitors LLP, gets into the weeds of how UK banks have been addressing the issue, as well as the prospects for improvement.

Kristina Spionjak discusses what will happen at Europe Canna Expo 2020, and reflects on opportunities for the medical cannabis industry.

George Thomas, Managing Director of Goodbody Botanicals, part of Sativa Group Plc, turn our thoughts towards the undoubted rise of cannabidiol (CBD).

Here, Paul Segal, chairman and co-founder of Symtomax, details what the most common myths about CBD are.

Jade Mansfield from British CBD Company, explains why it is so hard to know which CBD products to buy since its growth in popularity.

Promoting social science and humanities research in universities and colleges across Canada is charted here by Open Access Government.

Nature’s Creations provide all-natural CBD oil and aromatherapy products with 30 years of experience extracting pure botanicals.

Here, we focus on some of the key issues facing the pharmaceutical industry throughout Europe.

In this article, Dr Gerry Morrow shares his thoughts on the medical use of cannabinoids and marijuana.